Policy & Regulation
CHOSA Oncology signs US laboratory agreement for Platin-DRP commercialisation
4 November 2026 - Swedish precision oncology company CHOSA Oncology AB (Spotlight Stock Market: CHOSA) said on Wednesday it has signed an agreement with a CLIA-certified laboratory to develop and vali...
Agilent acquires Proscia for USD240m
4 November 2026 - Agilent Technologies Inc (NYSE: A), a provider of analytical and clinical laboratory technologies, announced on Wednesday that it has completed its acquisition of digital-pathology s...
BeOne Medicines wins FDA Priority Review for BRUKINSA combination in first-line mantle cell lymphoma
4 November 2026 - Oncology company BeOne Medicines Ltd (Nasdaq: ONC) (HKEX: 06160) (SSE: 688235) reported on Wednesday that it has received US Food and Drug Administration (FDA) Priority Review for it...
Sectra wins seven-year radiology reporting contract with Mount Sinai Health System
4 November 2026 - Sectra (STO: SECT B), a medical imaging IT and cybersecurity company, announced on Wednesday that it has signed a seven-year agreement with Mount Sinai Health System in New York to d...
Pentixapharm advances preparationsfor Phase 3 PANDA study
4 November 2026 - Biotechnology company Pentixapharm Holding AG (Frankfurt Prime Standard: PTP) on Wednesday reported further progress towards its pivotal Phase 3 PANDA study, with US ethics approval ...
ABIONYX Pharma partners with Lille University Hospital to explore CER-001 for severe burn patients
4 November 2026 - ABIONYX Pharma (Euronext Paris:ABNX), a biopharma company focused on breakthrough biotherapies to address life-threatening conditions with no effective treatments, announced on Wedne...